Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / PCRX - Heron Therapeutics: Cash Is A Problem Again

PCRX - Heron Therapeutics: Cash Is A Problem Again

Pacira BioSciences Inc.
  • Heron has lost 60% of its value in less than a year, despite the company making some progress.
  • Zynrelef's launch is slow but showing signs of improvement with some important inflection points.
  • CINV franchise has also disappointed and HTX-019 in PONV is now the only likely growth driver for this part of the business.
  • Heron is running low on cash again and needs to urgently address this issue in order to continue to execute the launch of Zynrelef.

For further details see:

Heron Therapeutics: Cash Is A Problem Again
Stock Information
Company Name: Pacira BioSciences Inc.
Stock Symbol: PCRX
Market: NASDAQ
Website: pacira.com
Menu
PCRX PCRX Quote PCRX Short PCRX News PCRX Articles PCRX Message Board
Get PCRX Alerts

News, Short Squeeze, Breakout and More Instantly...